IV ornithine phenylacetate: Completed Ph IIb STOP-HE enrollment

Ocera completed enrollment of about 230 hospitalized cirrhotic patients with elevated ammonia in the double-blind, placebo-controlled, international Phase IIb STOP-HE trial evaluating 10, 15 and 20 g ...